Porphyria with neuropsychiatric manifestations and contraceptive agents
Costantinidis, A.; Psomadakis, C.; Maurikakis, M.; Papageorgiou, C.
Minerva Ginecologica 25(4): 192-195
1973
ISSN/ISBN: 0026-4784 PMID: 4710129 Document Number: 66971
Document emailed within 1 workday
Related Documents
Massey, E.W. 1980: Neuropsychiatric manifestations of porphyria Journal of Clinical Psychiatry 41(6): 208-213Sixel-Dietrich, F.; Doss, M. 1985: Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication Archives of Dermatological Research 278(1): 13-16
Jensen, J.T. 2011: The future of contraception: innovations in contraceptive agents: tomorrow's hormonal contraceptive agents and their clinical implications American Journal of Obstetrics and Gynecology 205(4 Suppl): S21-S25
Benson, D.; Peterson, L.G.; Bartay, J. 1983: Neuropsychiatric manifestations of antihypertensive medications Psychiatric Medicine 1(2): 205-214
Cikes, N. 2009: Neuropsychiatric manifestations of systemic lupus erythematosus Reumatizam 56(2): 29-33
Alexa, I.D.; Stoica, M.S.; Paraschiv, O.; Rusu, R.I. 2006: Neuropsychiatric manifestations in systemic lupus erythematosus Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 110(2): 322-325
Maiti, A.; Chatterjee, S. 2013: Neuropsychiatric manifestations and their outcomes in chronic hypocalcaemia Journal of the Indian Medical Association 111(3): 174-177
Lajara-Nanson, W.A. 2000: Neuropsychiatric manifestations of a third ventricular colloid cyst West Virginia Medical Journal 96(4): 512-513
Marazziti, D.; Piccinni, A.; Mucci, F.; Baroni, S.; Loganovsky, K.; Loganovskaja, T. 2016: Ionizing radiation: brain effects and related neuropsychiatric manifestations Problemy Radiatsiinoi Medytsyny Ta Radiobiolohii 21: 64-90
Vyas, S.D.; Nayak, U.S.; Gandhi, D.J.; Shah, A.R. 1996: Childhood systemic lupus erythematosus presenting with neuropsychiatric manifestations Journal of the Indian Medical Association 94(2): 71; 73
Moreno-Flagge, N.; Bayard, V.; Quirós, E.; Alonso, T.ás. 2009: Acute encephalitis. Neuropsychiatric manifestations as expression of influenza virus infection Medicina 69(1 Part 1): 121-126
Pustovoĭt, I.S.; Pivnik, A.V.; Karpova, I.V. 1999: Clinical manifestations and diagnosis of acute porphyria Terapevticheskii Arkhiv 71(7): 76-80
Harel, L.; Sandborg, C.; Lee, T.; von Scheven, E. 2006: Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies Journal of Rheumatology 33(9): 1873-1877
Paz-Sendín, L.; Ledesma-Rivero, G.; Chalgub-Moreno, A.M.; Abrahan-Marcel, E.A.; Berroa-Díaz, F.; Allen-Hilton, W. 2001: Diagnostic difficulties in acute intermittent porphyria with neurological manifestations: apropos of 2 cases Revista de Neurologia 32(1): 96-97
Zoubek, V.; Martásek, P.; Kordac, V. 1987: Experience with the therapy of symptomatic liver porphyria using a combination of antimalarial agents--chloroquine with pyrimethamine Casopis Lekaru Ceskych 126(6): 170-173
Grilliat, J.P.; Moneretvautrin, D.A.; You, B.; Reynier, A. 1984: Manifestations respiratoires et intolérance à l'aspirine et aux anti-inflammatoires non stéroïdiens - Respiratory manifestations and aspirin intolerance and non steroid anti-inflammatory agents Annales de Medecine Interne (Paris) 135(1): 21-25
Kochetov, D.P.; Krivosheev, B.N. 1976: Scleroderma and porphyria cutanea tarda with clinical manifestations of scleroderma Vestnik Dermatologii i Venerologii 1: 64-68
Betancor León, P.; García Ruiz, F.; Font de Mora Turón, A.; López Martínez, J.; Schüller Pérez, A. 1980: Acute intermittent porphyria versus porphyria variegata: a diagnostic uncertainty Medicina Clinica 74(2): 61-64
Fakan, F.; Chlumská, A.; Krijt, J.; Kocová, L. 1998: Cytoplasmic liver cell inclusions--a typical feature of porphyria cutanea tarda--are absent in porphyria-related hepatic neoplasias Neoplasma 45(2): 102-106
Espinoza, C.G.; Fenske, N.A. 1988: Dermatological manifestations of toxic agents Annals of Clinical and Laboratory Science 18(2): 148-154